Disease: Acute Lymphoblastic Leukemia
Conditions
Brief summary
This study provides for the collection of a series composed by patients with newly diagnosed of acute lymphoblastic leukemia in the period 1999-2011. This collection is carried out with retrospective investigation, through the review of paper and electronic records and data cards in large part already collected as part of study protocols GIMEMA or BFM or NILG approved by the Ethics Committee of Hospital. The purpose of data collection is to check with retrospective predictability of classical risk factors in relation to disease response, and overall survival of the event-free survival, to estimate the cumulative incidence of competitive events such as the emergence of disease, acute and chronic transplant, the transplant-related mortality and relapse of disease.
Interventions
None listed
Sponsors
Azienda Ospedaliera San Giovanni Battista
Study design
Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Patients with newly diagnosed of acute lymphoblastic leukemia enrolled from 1999 to 2011 at the Division of Hematology, Molinette University Hospital and candidates for therapeutic approach with curative intent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall survival | 1 year |
| Event-free survival | 1 year |
Countries
Italy
Contacts
Primary ContactBenedetto Bruno, MD
Backup ContactBenedetto Bruno, MD
Outcome results
None listed